Cargando…
mRNA-Based Protein Replacement Therapy for the Heart
Myocardial infarction (MI) and heart failure (HF) are the leading causes of death in the United States and in most other industrialized nations. MI leads to a massive loss of cardiomyocytes (CMs), which are replaced with non-CM cells, leading to scarring and, in most cases, HF. The adult mammalian h...
Autores principales: | Magadum, Ajit, Kaur, Keerat, Zangi, Lior |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453506/ https://www.ncbi.nlm.nih.gov/pubmed/30611663 http://dx.doi.org/10.1016/j.ymthe.2018.11.018 |
Ejemplares similares
-
Modified mRNA as a Therapeutic Tool for the Heart
por: Kaur, Keerat, et al.
Publicado: (2020) -
Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy
por: Hadas, Yoav, et al.
Publicado: (2019) -
Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury
por: Sultana, Nishat, et al.
Publicado: (2020) -
Modified mRNA Therapeutics for Heart Diseases
por: Magadum, Ajit
Publicado: (2022) -
Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
por: Magadum, Ajit, et al.
Publicado: (2021)